Developer docs
API playgroundTry for free, no card

Search company profiles

LactaLogics

Full company profile

uuid0000hrd

Namestring
LactaLogics
Legal namestring
LactaLogics, Inc.
Websiteurl
lactalogics.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

LactaLogics is a privately held human milk-based nutrition company headquartered in Port St. Lucie, Florida, founded in 2014 (originally as International Milk Bank, rebranded in 2020). The company develops and intends to commercialize a portfolio of 100% human milk-based products — donor human milk, human milk-based fortifier (available in standardized 18 and 20 calorie options), and BridgePacks — for premature and at-risk infants in hospital NICUs and, on a planned basis, in outpatient home-use settings. Its core innovation is the proprietary Gentle-UHT process: indirect ultra-high temperature pasteurization paired with bactofugation and light homogenization, validated across more than 50 R&D and commercial-scale runs at Tetra Pak's pilot facility in Denton, Texas. The technology achieves over a 1,000 log reduction of Bacillus cereus spores while retaining more than 90% of proteins, immune factors, and HMOs, producing shelf-stable human milk that does not require freezing or thawing. Aseptic packaging is delivered through a partnership with Scholle IPN.

The company's revenue model centers on direct hospital procurement of human milk-based fortifiers and ready-to-feed donor milk for NICUs, with a future physician-prescribed outpatient/home-use channel and a Donor Success Program that supplies raw milk through a screened donor network compensated via Fast-Reimburse within two weeks. The GTM is enterprise field sales targeting neonatologists, NICU nurses, lactation consultants, and hospital procurement teams. As of early 2026, LactaLogics is pre-commercial at scale: a 72,000 sq ft processing facility in Port St. Lucie is at 95% completion with production scheduled for the first half of 2026 and planned annual capacity of 60 million ounces, against an estimated U.S. market need of more than 100 million ounces annually. The company closed over $92 million in financing in March 2024 (USDA Food Safety Loan via Magnolia Bank, DOE CPACE Loan via PACE Equity, state and local government support, and private capital from McCarvill Capital Partners) to fund facility construction. Headcount is 11-50 and revenue is not publicly disclosed.

Short descriptiontext

LactaLogics is a Florida-based nutrition company developing shelf-stable, 100% human milk-based products — including donor milk and fortifiers — using proprietary Gentle-UHT processing for hospital NICUs and outpatient families caring for premature and at-risk infants.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPort St. Lucie, United States
HQ citystring
Port St. Lucie
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
human milk nutrition, neonatal nutrition products, donor milk processing, milk-based fortifier, NICU infant feeding
Industry3 codes
PRIMARYAFAKAKAJ
Infant Formula & Specialized Dairy Nutrition Manufacturing
SECONDARYAFAHAAAD
UHT/Aseptic Fluid Milk Processing
Agriculture & Food Production/Dairy Processing/Fluid Milk Processing (Pasteurized, ESL, UHT)
SECONDARYCRADACAA
Milk (Fluid & Shelf-Stable)
NAICS code2 codes
  • Dairy Product (except Frozen) Manufacturing31151
  • Fluid Milk Manufacturing311511
SIC code1 code
  • Dairy Products2020
Product category
Neonatal Nutrition Products
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Human Milk-Based Fortifier Sales
TypeOne Time License
Description

LactaLogics sells 100% human milk-based fortifier products to hospital NICUs. The fortifier works in partnership with mom's milk to deliver concentrated nutrition premature infants need. Products are available in standardized calorie and protein content options (18 and 20 calorie products). Revenue is generated through direct hospital procurement contracts.

lactalogics.com
2Ready-to-Feed Donor Human Milk
TypeOne Time License
Description

Shelf-stable, aseptically packaged donor human milk sold to hospitals and families for use in NICUs and home care settings. Distributed via clinical channels with physician involvement. The product addresses supplementation gaps for both premature and full-term infants.

lactalogics.com
3Donor Program Services
TypeProfessional Services
Description

LactaLogics operates a donor support program connecting milk donors with infants in need. Donors receive reimbursement through the company's Fast-Reimburse Program. The program supports the company's raw material supply chain for processing.

lactalogics.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Infrastructure, Technology or R&D, Supply Chain, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

LactaLogics develops and produces 100% human milk-based nutritional products, including shelf-stable donor human milk and human milk-based fortifiers, processed through its proprietary Gentle-UHT indirect ultra-high temperature pasteurization platform combined with bactofugation and light homogenization. The products are sold primarily to hospital NICUs for premature and at-risk infants, with planned outpatient distribution to families via physician prescription.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 93% of infants successfully transitioned from donor human milk supplementation to exclusive breastfeeding in a pilot study
+5 more records
Product overview1 text field

LactaLogics is a human milk-based nutrition company offering a portfolio of 100% human milk-based products designed to support premature and at-risk infants from the NICU to at-home care. The core product portfolio includes Donor Human Milk (shelf-stable, processed via Gentle-UHT), Human Milk-Based Fortifier (works with mother's milk), and BridgePacks (outpatient supplement alternative to formula). All products utilize the proprietary Gentle-UHT processing technology which enables superior protein retention while ensuring safety through indirect heat treatment, resulting in products that can be stored at room temperature without refrigeration.

Product and service1 record
1Donor Human Milk
Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1Dennis Group
Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2024-12-30
Description

Dennis Group is the award-winning design-builder contracted for the construction of LactaLogics' 70,000-square-foot human milk processing facility in Port St. Lucie, Florida. The firm is dedicated to delivering a world-class facility that meets the highest food safety standards while supporting the unique requirements of human milk processing.

lactalogics.com
2NEC Society
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-06-22
Description

LactaLogics serves as a 2022 Champion for the NEC Society, a non-profit dedicated to creating a world without necrotizing enterocolitis. As a Champion, LactaLogics helps drive research, education, and advocacy for premature and medically vulnerable infants at risk of NEC — the leading cause of morbidity and mortality in the NICU.

lactalogics.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-01-05
Description

Scholle IPN is a global flexible packaging manufacturer specializing in aseptic packaging technology. The partnership gives hospitals access to pharmaceutical-grade aseptic packaging technology that does not require refrigeration and minimizes open-air mixing, revolutionizing how human milk is administered in NICU settings. LactaLogics' human milk-based products are packaged in aseptic pouches and cartons.

4Tetra Pak
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-12-30
Description

Tetra Pak, a Sweden-based world-leading food processing and packaging solutions company, completed engineering work with LactaLogics for large-scale manufacturing. LactaLogics conducted three commercial-grade processing runs at Tetra Pak's Denton, Texas Product Development Center prior to finalizing the engineering agreement. The partnership validates LactaLogics' approach for aseptic processing and all parts of large-scale manufacturing, positioning the company to produce 60 million ounces of human milk-based products per year.

lactalogics.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Prolacta is the dominant US producer of 100% human milk-based fortifiers and standardized donor milk for NICUs, competing head-to-head with LactaLogics in the same hospital channel with the same product category. Its former Chief Medical and Scientific Officer (Dr. Victoria Niklas) now sits on LactaLogics' board, underscoring how directly the two companies compete.

TypeDirect peer
Description

Medolac is a US-based human milk biopharmaceutical company producing shelf-stable donor human milk products for hospital and clinical use. It competes with LactaLogics in the same donor-milk, NICU-focused category and similarly targets improvements over traditional Holder pasteurization.

TypeEmerging player
Description

NeoKare is a UK-based human milk processor producing pasteurized donor human milk and related neonatal nutritional products for hospital use. It is an emerging player in the same product category with overlapping technology goals (improved processing of human milk for preterm infants) but serves primarily European hospitals.

TypeBroad incumbent
Description

Mead Johnson, owner of the Enfamil brand, is a global incumbent in infant formula and pediatric nutrition sold into the same hospital NICU and outpatient channels that LactaLogics targets. While its products are bovine-based rather than human-milk-based, it competes for the same feeding-decision wallet share in NICUs and at home.

TypeBroad incumbent
Description

Abbott's Similac brand is a leading infant formula sold into US hospital NICUs and retail, directly competing for the nutritional decision LactaLogics targets with its donor human milk and fortifier. Abbott is a broad incumbent across the full neonatal nutrition category, including specialty formulas for preterm infants.

TypeBroad incumbent
Description

Nestlé Health Science offers infant formula, preterm nutrition, and pediatric medical nutrition products sold into hospital and outpatient channels globally. It competes for neonatal nutritional decisions alongside LactaLogics and could expand into human milk-based offerings over time.

TypeBroad incumbent
Description

Danone's Nutricia division is a global leader in early-life nutrition, including preterm and specialty infant formulas sold into hospital NICUs and through retail. It is a broad incumbent competing for the same feeding decisions as LactaLogics, particularly in Europe.

8Perrigo Nutritionals
TypeBroad incumbent
Description

Perrigo manufactures store-brand and specialty infant formulas distributed through US hospitals and retail, competing in the same preterm and full-term infant feeding decisions as LactaLogics. It is a broad incumbent in pediatric nutrition with established hospital relationships.

TypeEmerging player
Description

Bobbie is a US-based organic infant formula startup focused on the direct-to-consumer and outpatient channel, where LactaLogics plans to compete with its BridgePack home-use line. While Bobbie is bovine-based rather than human-milk-based, it competes for the same supplementation and feeding-decision use cases among new parents.

TypeOthers
Description

HMBANA is a network of nonprofit donor human milk banks that supply pasteurized human milk to US hospitals. They are not direct commercial peers but represent the traditional supply channel LactaLogics is competing with and potentially displacing through shelf-stable, scalable manufacturing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LactaLogics

Neonatal Nutrition Productslactalogics.com

LactaLogics is a Florida-based nutrition company developing shelf-stable, 100% human milk-based products — including donor milk and fortifiers — using proprietary Gentle-UHT processing for hospital NICUs and outpatient families caring for premature and at-risk infants.

What LactaLogics does

LactaLogics is a privately held human milk-based nutrition company headquartered in Port St. Lucie, Florida, founded in 2014 (originally as International Milk Bank, rebranded in 2020). The company develops and intends to commercialize a portfolio of 100% human milk-based products — donor human milk, human milk-based fortifier (available in standardized 18 and 20 calorie options), and BridgePacks — for premature and at-risk infants in hospital NICUs and, on a planned basis, in outpatient home-use settings. Its core innovation is the proprietary Gentle-UHT process: indirect ultra-high temperature pasteurization paired with bactofugation and light homogenization, validated across more than 50 R&D and commercial-scale runs at Tetra Pak's pilot facility in Denton, Texas. The technology achieves over a 1,000 log reduction of Bacillus cereus spores while retaining more than 90% of proteins, immune factors, and HMOs, producing shelf-stable human milk that does not require freezing or thawing. Aseptic packaging is delivered through a partnership with Scholle IPN.

The company's revenue model centers on direct hospital procurement of human milk-based fortifiers and ready-to-feed donor milk for NICUs, with a future physician-prescribed outpatient/home-use channel and a Donor Success Program that supplies raw milk through a screened donor network compensated via Fast-Reimburse within two weeks. The GTM is enterprise field sales targeting neonatologists, NICU nurses, lactation consultants, and hospital procurement teams. As of early 2026, LactaLogics is pre-commercial at scale: a 72,000 sq ft processing facility in Port St. Lucie is at 95% completion with production scheduled for the first half of 2026 and planned annual capacity of 60 million ounces, against an estimated U.S. market need of more than 100 million ounces annually. The company closed over $92 million in financing in March 2024 (USDA Food Safety Loan via Magnolia Bank, DOE CPACE Loan via PACE Equity, state and local government support, and private capital from McCarvill Capital Partners) to fund facility construction. Headcount is 11-50 and revenue is not publicly disclosed.

LactaLogics firmographics

Firmographics
Name
LactaLogics
Legal name
LactaLogics, Inc.
Website
https://lactalogics.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
LactaLogics is a Florida-based nutrition company developing shelf-stable, 100% human milk-based products — including donor milk and fortifiers — using proprietary Gentle-UHT processing for hospital NICUs and outpatient families caring for premature and at-risk infants.
Ownership category
akta.pro rank

LactaLogics industry classification

Industry
Product category
Neonatal Nutrition Products
NAICS
Dairy Product (except Frozen) Manufacturing (31151), Fluid Milk Manufacturing (311511)
SIC
Dairy Products (2020)
akta.pro industry
PRIMARYAFAKAKAJ
Infant Formula & Specialized Dairy Nutrition Manufacturing
SECONDARYAFAHAAAD
UHT/Aseptic Fluid Milk Processing
Agriculture & Food Production/Dairy Processing/Fluid Milk Processing (Pasteurized, ESL, UHT)
SECONDARYCRADACAA
Milk (Fluid & Shelf-Stable)

Keywords

  • Human milk nutrition
  • Neonatal nutrition products
  • Donor milk processing
  • Milk-based fortifier
  • NICU infant feeding

Where LactaLogics is headquartered

Location

Headquarters

HQ city
Port St. Lucie
HQ country
United States
HQ region
North America

Offices2 records

Markets served

LactaLogics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Infrastructure, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. Human Milk-Based Fortifier Sales: LactaLogics sells 100% human milk-based fortifier products to hospital NICUs. The fortifier works in partnership with mom's milk to deliver concentrated nutrition premature infants need. Products are available in standardized calorie and protein content options (18 and 20 calorie products). Revenue is generated through direct hospital procurement contracts.
  2. Ready-to-Feed Donor Human Milk: Shelf-stable, aseptically packaged donor human milk sold to hospitals and families for use in NICUs and home care settings. Distributed via clinical channels with physician involvement. The product addresses supplementation gaps for both premature and full-term infants.
  3. Donor Program Services: LactaLogics operates a donor support program connecting milk donors with infants in need. Donors receive reimbursement through the company's Fast-Reimburse Program. The program supports the company's raw material supply chain for processing.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

LactaLogics product offering

Product offering

Core offering

LactaLogics develops and produces 100% human milk-based nutritional products, including shelf-stable donor human milk and human milk-based fortifiers, processed through its proprietary Gentle-UHT indirect ultra-high temperature pasteurization platform combined with bactofugation and light homogenization. The products are sold primarily to hospital NICUs for premature and at-risk infants, with planned outpatient distribution to families via physician prescription.

Product overview

LactaLogics is a human milk-based nutrition company offering a portfolio of 100% human milk-based products designed to support premature and at-risk infants from the NICU to at-home care. The core product portfolio includes Donor Human Milk (shelf-stable, processed via Gentle-UHT), Human Milk-Based Fortifier (works with mother's milk), and BridgePacks (outpatient supplement alternative to formula). All products utilize the proprietary Gentle-UHT processing technology which enables superior protein retention while ensuring safety through indirect heat treatment, resulting in products that can be stored at room temperature without refrigeration.

Differentiator

Problem solved

Functional benefit

Products and services

  • Donor Human Milk

Quantifiable outcome

  • 93% of infants successfully transitioned from donor human milk supplementation to exclusive breastfeeding in a pilot study
  • +5 more outcomes

Companies that use LactaLogics

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

LactaLogics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

LactaLogics partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Dennis GroupcoreImplementation/ SI/ Consulting Partner · 30 December 2024Dennis Group is the award-winning design-builder contracted for the construction of LactaLogics' 70,000-square-foot human milk processing facility in Port St. Lucie, Florida. The firm is dedicated to delivering a world-class facility that meets the highest food safety standards while supporting the unique requirements of human milk processing.
  • NEC SocietyminorStrategic or Co-development Partner · 22 June 2022LactaLogics serves as a 2022 Champion for the NEC Society, a non-profit dedicated to creating a world without necrotizing enterocolitis. As a Champion, LactaLogics helps drive research, education, and advocacy for premature and medically vulnerable infants at risk of NEC — the leading cause of morbidity and mortality in the NICU.
  • Scholle IPNcoreTechnology or Integration · 5 January 2022Scholle IPN is a global flexible packaging manufacturer specializing in aseptic packaging technology. The partnership gives hospitals access to pharmaceutical-grade aseptic packaging technology that does not require refrigeration and minimizes open-air mixing, revolutionizing how human milk is administered in NICU settings. LactaLogics' human milk-based products are packaged in aseptic pouches and cartons.
  • Tetra PakcoreTechnology or Integration · 30 December 2021Tetra Pak, a Sweden-based world-leading food processing and packaging solutions company, completed engineering work with LactaLogics for large-scale manufacturing. LactaLogics conducted three commercial-grade processing runs at Tetra Pak's Denton, Texas Product Development Center prior to finalizing the engineering agreement. The partnership validates LactaLogics' approach for aseptic processing and all parts of large-scale manufacturing, positioning the company to produce 60 million ounces of human milk-based products per year.

Scale indicators11 records

Recent moves8 records

Expansion highlights7 records

LactaLogics competitors and assessment

Company assessment

Direct peers

  • Prolacta Bioscience: Prolacta is the dominant US producer of 100% human milk-based fortifiers and standardized donor milk for NICUs, competing head-to-head with LactaLogics in the same hospital channel with the same product category. Its former Chief Medical and Scientific Officer (Dr. Victoria Niklas) now sits on LactaLogics' board, underscoring how directly the two companies compete.
  • Medolac Laboratories: Medolac is a US-based human milk biopharmaceutical company producing shelf-stable donor human milk products for hospital and clinical use. It competes with LactaLogics in the same donor-milk, NICU-focused category and similarly targets improvements over traditional Holder pasteurization.

Emerging players

  • NeoKare: NeoKare is a UK-based human milk processor producing pasteurized donor human milk and related neonatal nutritional products for hospital use. It is an emerging player in the same product category with overlapping technology goals (improved processing of human milk for preterm infants) but serves primarily European hospitals.
  • Bobbie: Bobbie is a US-based organic infant formula startup focused on the direct-to-consumer and outpatient channel, where LactaLogics plans to compete with its BridgePack home-use line. While Bobbie is bovine-based rather than human-milk-based, it competes for the same supplementation and feeding-decision use cases among new parents.

Broad incumbents

  • Mead Johnson Nutrition (Reckitt): Mead Johnson, owner of the Enfamil brand, is a global incumbent in infant formula and pediatric nutrition sold into the same hospital NICU and outpatient channels that LactaLogics targets. While its products are bovine-based rather than human-milk-based, it competes for the same feeding-decision wallet share in NICUs and at home.
  • Abbott Nutrition: Abbott's Similac brand is a leading infant formula sold into US hospital NICUs and retail, directly competing for the nutritional decision LactaLogics targets with its donor human milk and fortifier. Abbott is a broad incumbent across the full neonatal nutrition category, including specialty formulas for preterm infants.
  • Nestlé Health Science: Nestlé Health Science offers infant formula, preterm nutrition, and pediatric medical nutrition products sold into hospital and outpatient channels globally. It competes for neonatal nutritional decisions alongside LactaLogics and could expand into human milk-based offerings over time.
  • Danone Nutricia: Danone's Nutricia division is a global leader in early-life nutrition, including preterm and specialty infant formulas sold into hospital NICUs and through retail. It is a broad incumbent competing for the same feeding decisions as LactaLogics, particularly in Europe.
  • Perrigo Nutritionals: Perrigo manufactures store-brand and specialty infant formulas distributed through US hospitals and retail, competing in the same preterm and full-term infant feeding decisions as LactaLogics. It is a broad incumbent in pediatric nutrition with established hospital relationships.

Others

  • Human Milk Banking Association of North America (HMBANA) member banks: HMBANA is a network of nonprofit donor human milk banks that supply pasteurized human milk to US hospitals. They are not direct commercial peers but represent the traditional supply channel LactaLogics is competing with and potentially displacing through shelf-stable, scalable manufacturing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

LactaLogics social profiles

Digital presence

LactaLogics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LactaLogics leadership team

Management profile

Number of profiles

Profiles14 records

LactaLogics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LactaLogics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LactaLogics

What does LactaLogics do?

LactaLogics develops and produces 100% human milk-based nutritional products, including shelf-stable donor human milk and human milk-based fortifiers, processed through its proprietary Gentle-UHT indirect ultra-high temperature pasteurization platform combined with bactofugation and light homogenization. The products are sold primarily to hospital NICUs for premature and at-risk infants, with planned outpatient distribution to families via physician prescription.

Is LactaLogics a public or private company?

LactaLogics is a private company. It is classified as venture growth investor backed and is currently operating.

When was LactaLogics founded?

LactaLogics was founded in 2014. It employs 11 to 50 people.

Where is LactaLogics based?

LactaLogics is headquartered in Port St. Lucie, United States, in the North America region.

How does LactaLogics make money?

Three revenue lines are on record. Human Milk-Based Fortifier Sales are the primary driver. The others are ready-to-Feed Donor Human Milk and donor Program Services.

Who are LactaLogics's main competitors?

Direct peers on record are Prolacta Bioscience and Medolac Laboratories. Emerging players are NeoKare and Bobbie. Broad incumbents are Mead Johnson Nutrition (Reckitt), Abbott Nutrition, Nestlé Health Science, Danone Nutricia and Perrigo Nutritionals. Human Milk Banking Association of North America (HMBANA) member banks is listed as an others.

Does LactaLogics have an API?

No public API is recorded for LactaLogics.

What industry is LactaLogics in?

LactaLogics's product category is Neonatal Nutrition Products. Its primary akta.pro industry code is AFAKAKAJ, Infant Formula & Specialized Dairy Nutrition Manufacturing, with a secondary code of AFAHAAAD, UHT/Aseptic Fluid Milk Processing. Its NAICS code is 31151 and its SIC code is 2020.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PRLogLactaLogics Nears Completion of Donor Milk Facility for NICU BabiesLactaLogics announced that its new 72,000-square-foot human milk processing facility in Port St. Lucie, Florida is nearing completion at 95 percent readiness, with final commissioning underway. The facility remains on track to begin human milk production in the first half of 2026, expanding access to shelf-stable donor human milk for premature and at-risk infants in hospital and home care settings. The plant was designed to scale with growing demand and will support the company's Donor Success Program connecting milk donors with infants in need.Pulse 2.0LactaLogics: Human Milk-Based Nutrition Company Raises Over $92 MillionLactaLogics raised over $92 million in funding from USDA, DOE, and private investors. The company will use the funds to build a 71,000-square-foot facility in Port St. Lucie, Florida, for producing human milk-based fortifiers and standardized donor milk. The facility aims to expand access to human milk for infants in NICUs and at home.LactalogicsLactaLogics closes $92 million for facility, expanding access to human milkLactaLogics has closed over $92 million in financing to complete a state-of-the-art facility in Port St. Lucie, Florida, for the production of human milk-based fortifiers and standardized donor milk. The funding, sourced from USDA loans via Magnolia Bank, US DOE CPACE loans underwritten by PACE Equity, and private investors including McCarvill Capital Partners, will support the company's proprietary Gentle-UHT™ processing technology. This expansion aims to address supply constraints in neonatal intensive care units and provide reliable nutritional options for infants.VC News DailyLactaLogics Closes $92 MillionLactaLogics has closed over $92 million in financing, secured through USDA and DOE loans as well as private investors. This capital will fund the completion of its state-of-the-art facility for producing human milk-based fortifiers and standardized donor milk.PrwebLactaLogics Closes $92 Million for Facility, Expanding Access to Human MilkLactaLogics closed over $92 million in financing to complete its state-of-the-art facility for producing human milk-based fortifiers and standardized donor milk. This funding addresses the limited availability of human milk products in neonatal intensive care units and for home use, aiming to provide more nutritional options for infants.